A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years

BACKGROUND: Current influenza vaccines have reduced immunogenicity and are of uncertain efficacy in older adults. We assessed the safety and immunogenicity of MVA-NP+M1, a viral-vectored influenza vaccine designed to boost memory T cell responses, in a group of older adults. METHODS: Thirty voluntee...

Descripción completa

Detalles Bibliográficos
Autores principales: Antrobus, Richard D., Lillie, Patrick J., Berthoud, Tamara K., Spencer, Alexandra J., McLaren, James E., Ladell, Kristin, Lambe, Teresa, Milicic, Anita, Price, David A., Hill, Adrian V. S., Gilbert, Sarah C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485192/
https://www.ncbi.nlm.nih.gov/pubmed/23118984
http://dx.doi.org/10.1371/journal.pone.0048322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485192/
https://www.ncbi.nlm.nih.gov/pubmed/23118984
http://dx.doi.org/10.1371/journal.pone.0048322

Ejemplares similares